Clarithromycin Susceptibility-Guided Treatment of Helicobacter Pylori Infection

• Status: Recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to assess the safety and efficacy of clarithromycin susceptibility-guided therapy as the first line treatment for H pylori infection compared with empirical bismuth-containing quadruple therapy.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Liaocheng People's Hospital
• Treatments: Amoxicillin; Bismuth; Clarithromycin; Fluoroquinolones

Criteria

Inclusion Criteria:

• patients for first-line treatment of Helicobacter pylori infection

Exclusion Criteria:

• penicillin allergy

• pregnancy and lactation